Literature DB >> 11778983

Empowering primary care health professionals in medical genetics: how soon? How fast? How far?

K Greendale1, R E Pyeritz.   

Abstract

Applications of genetics to the practices of medicine and public health are important today and will only become more compelling as our understanding of the human genome evolves. Because of a perceived lack of medical genetics professionals, it is generally believed that primary health care providers (PCPs) will need to assume prominent roles in delivering clinical genetics services. However, a number of studies indicate that most PCPs are neither well enough educated in genetics nor interested enough in becoming so to effectively contribute. Those who advocate empowering PCPs must be aware of potential problems with any approach thus far suggested for achieving this goal. Moreover, any analysis of this model must consider the potential ramifications for medical genetics professionals, patients, and families. In this article, we explore some of the unique features of the culture of medical genetics services and service providers. We discuss how important this culture is to clinical outcomes and the likelihood that its positive attributes would be preserved in a PCP model of medical genetics service delivery.

Entities:  

Mesh:

Year:  2001        PMID: 11778983     DOI: 10.1002/ajmg.10010

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  38 in total

1.  Psychosocial genetic counseling in the post-nondirective era: a point of view.

Authors:  Jon Weil
Journal:  J Genet Couns       Date:  2003-06       Impact factor: 2.537

2.  Genetic counselling in the era of genomic medicine. As we move towards personalized medicine, it becomes more important to help patients understand genetic tests and make complex decisions about their health.

Authors:  Jon Weil
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

3.  Development of a questionnaire for evaluating genetics education in general practice.

Authors:  Anna Flouris; Graeme Hawthorne; Maryanne Aitken; Clara Gaff; Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2010-10-16

4.  Multilevel research and the challenges of implementing genomic medicine.

Authors:  Muin J Khoury; Ralph J Coates; Mary L Fennell; Russell E Glasgow; Maren T Scheuner; Sheri D Schully; Marc S Williams; Steven B Clauser
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

5.  The use of a family history risk assessment tool within a community health care system: views of primary care providers.

Authors:  Carol A Christianson; Karen Potter Powell; Susan Estabrooks Hahn; Susan H Blanton; Jessica Bogacik; Vincent C Henrich
Journal:  J Genet Couns       Date:  2012-01-21       Impact factor: 2.537

6.  Genetics education for health professionals: a context.

Authors:  Joseph D McInerney
Journal:  J Genet Couns       Date:  2007-10-19       Impact factor: 2.537

Review 7.  Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.

Authors:  Katherine I Morley; Wayne D Hall
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

8.  Genetic education for primary care providers: improving attitudes, knowledge, and confidence.

Authors:  June C Carroll; Andrea L Rideout; Brenda J Wilson; Judith Md Allanson; Sean M Blaine; Mary Jane Esplen; Sandra A Farrell; Gail E Graham; Jennifer MacKenzie; Wendy Meschino; Fiona Miller; Preeti Prakash; Cheryl Shuman; Anne Summers; Sherry Taylor
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

9.  Cancer genetic risk assessment and referral patterns in primary care.

Authors:  Hetal S Vig; Joanne Armstrong; Brian L Egleston; Carla Mazar; Michele Toscano; Angela R Bradbury; Mary B Daly; Neal J Meropol
Journal:  Genet Test Mol Biomarkers       Date:  2009-12

10.  "Would you test your children without their consent?" and other sticky dilemmas in the field of cancer genetic testing.

Authors:  Karina L Brierley; Danielle C Bonadies; Anne Moyer; Ellen T Matloff
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.